Scroll back to top

Posted July 3, 2018

MNG Laboratories, Pronto Diagnostics Partner To Offer Clinical RNA Sequencing


MNG Laboratories, an Atlanta-based neurogenetic testing company, is pleased to announce that it has signed a Distribution Agreement with Pronto Diagnostics, a leading Israeli genomics company, to exclusively market its complete line of Clinical RNA Sequencing Services in Israel.

To read the full press release, click here.

Related News

MNG is Transitioning to Labcorp's New Brand

MNG specimen collection kits will be transitioning to Labcorp's brand.

MNG Expands Global Reach With Several New Distributors

MNG Laboratories is pleased to announce the signing of several key international distributor agreements in Asia, Latin America and Eastern Europe.